Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360…

Roche has received approval through the EU’s In Vitro diagnostic regulation for several label expansions of its companion diagnostic platform…

Predicta Biosciences, a precision oncology specialist, is teaming with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics clinic to offer…

Galmed Pharmaceuticals acquired Colospan in a $4.5 million deal as the Israel-based biotech looks to create a gastrointestinal platform targeting…

As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will…

Swiss medtech CeQur has raised $100 million in a new series E funding round for what it called its “most…

A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in…

Resmed has closed its $340 million acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes the sleep…

Insulet, the diabetes device maker, debuted upgrades to its popular Omnipod 5 tubeless automated insulin delivery system. The new features…

British medtech startup IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune…